O10 Dépistage systématique associé à une prise en charge intensive du diabète gestationnel : quels bénéfices pour quelles patientes ?
Nicolas Chevalier(Inserm), Patrick Fénichel(Inserm), V. Giaume, A. Bongain, G. Daideri, S. Hiéronimus(Université Toulouse III - Paul Sabatier)
Cited by 2
Related Papers
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
The Minderoo-Monaco Commission on Plastics and Human Health
|Annals of Global Health|2023|423
Bisphenol A: An endocrine and metabolic disruptor
|Annales d Endocrinologie|2013|278
Phenotypical, Biological, and Molecular Heterogeneity of 5α-Reductase Deficiency: An Extensive International Experience of 55 Patients
|The Journal of Clinical Endocrinology & Metabolism|2010|213
Obesity II: Establishing causal links between chemical exposures and obesity
|Biochemical Pharmacology|2022|197